Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
How might mavacamten aid in the treatment of obstructive hypertrophic cardiomyopathy? Explore the latest findings in this session recap from ACC 2022.
